Clinical characteristics of 1139 mild cases of the SARS‐CoV‐2 Omicron variant infected patients in Shanghai

M Wang, Z Liu, Z Wang, K Li, Y Tian… - Journal of Medical …, 2023 - Wiley Online Library
Abstract In March 2022, the Omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) surged during the Coronavirus Disease 2019 (COVID‐19) …

[HTML][HTML] SARS-CoV-2 omicron (B. 1.1. 529) variant: a challenge with COVID-19

Z Mohseni Afshar, A Tavakoli Pirzaman, B Karim… - Diagnostics, 2023 - mdpi.com
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there have
been multiple peaks of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus …

[HTML][HTML] Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review

Z Chen, Y Zhang, M Wang, MS Islam… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has undergone
multiple mutations since its emergence, and its latest variant, Omicron (B. 1.1. 529), is the …

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents

C Ma, X Chen, F Mei, Q Xiong, Q Liu… - Emerging microbes & …, 2022 - Taylor & Francis
Global concern has been raised by the emergence and rapid transmission of the heavily
mutated SARS-CoV-2 Omicron variant (B. 1.1. 529). So far, the infection features and …

[HTML][HTML] SARS‐CoV‐2 Omicron variant is spreading in different parts of the world in three different trends

PA Desingu, K Nagarajan - Journal of Medical Virology, 2022 - ncbi.nlm.nih.gov
Dear Editor, The COVID‐19 cases in India were 9195 new cases/day on December 28,
2021, after which the number of new cases/day skyrocketed everyday, and on January 13 …

[HTML][HTML] Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or …

M Peiris, S Cheng, CKP Mok, Y Leung, S Ng… - Research …, 2022 - ncbi.nlm.nih.gov
Omicron, a novel SARS-CoV-2 variant has emerged and is rapidly becoming the dominant
SARS-CoV-2 virus circulating globally. It is important to define reductions in virus …

[HTML][HTML] Retention of neutralizing response against SARS-CoV-2 omicron variant in sputnik V-Vaccinated individuals

D Lapa, DM Grousova, G Matusali, S Meschi… - Vaccines, 2022 - mdpi.com
The new Omicron variant of SARS-CoV-2, first identified in November 2021, is rapidly
spreading all around the world. Omicron has become the dominant variant of SARS-CoV-2 …

[HTML][HTML] Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB. 1.5, BQ. 1, BQ. 1.1, BF. 7 and BA. 2.75. 2

A Zhu, P Wei, M Man, X Liu, T Ji, J Chen… - Signal transduction and …, 2023 - nature.com
Recently, a number of new Omicron subvariants related to BA. 4/5 and BA. 2.75 have
emerged and shown remarkable antibody evasion capacities, in particular BF. 7, BQ. 1, BQ …

Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study

RK Mohapatra, S Mishra, V Kandi… - Health Science …, 2023 - Wiley Online Library
Abstract Background and Aim Understanding the prevalence and impact of SARS‐CoV‐2
variants has assumed paramount importance. This study statistically analyzed to effectively …

[HTML][HTML] Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa

Y Liu, Y Yu, Y Zhao, D He - International Journal of Infectious Diseases, 2022 - Elsevier
Abstract Objective The SARS-CoV-2 Omicron (B. 1.1. 529) variant has caused global
concern. Previous studies have shown that the variant has enhanced immune evasion …